Lymphoma Canada urges governments to speed up access to approved cancer drugs

We urge the federal government to adopt a modernized approach to its current reimbursement recommendation framework and work with patients, oncologists, manufacturers, regulators and payers to develop mechanisms to improve access to effective treatment options for those living with cancer.

Canada's federal Health Minister Ginette Petitpas Taylor, pictured with former Ontario health minister Eric Hoskins, who will now chair the federal government's advisroy council to implement a national pharmacare plan, on the Hill on Feb. 27, 2018. The Hill Times photograph by Sam Garcia

Opinion

BY ROBIN MARKOWITZ

April 23, 2018

Strides in cancer research have increased survival rates and provided a better quality of life for patients under treatment. But getting the best treatment as soon as possible remains a matter of life and death for many Canadians. Speed is of the essence. Patients and families live with the hope tha...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Weekend Point of View Newsletter

A round up of the past weekâ€™s opinion writers and columnists on Saturdays and Sundays.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy